{
    "title": "108_s2038",
    "content": "The \"Flu Protection Act of 2004\" includes a section on a Flu Vaccine Awareness Campaign, which amends the Public Health Service Act to include an influenza vaccine awareness campaign and education and outreach efforts. The \"Flu Protection Act of 2004\" mandates a public awareness campaign led by the Secretary of Health and Human Services to promote influenza vaccination, target recommended populations, educate healthcare providers, and emphasize vaccine safety and efficacy. The \"Flu Protection Act of 2004\" mandates a public awareness campaign to promote influenza vaccination and urges early preordering of vaccines for Medicare recipients to ensure production levels meet the needs. The Director will work with Medicare services to publish immunization rates among individuals receiving assistance under the program. The \"Flu Protection Act of 2004\" authorizes $10,000,000 for State adult immunization programs focusing on improving influenza vaccine delivery to high-risk populations. The Director will assess the efficacy of the influenza vaccine and may use existing communication structures for public awareness campaigns. Title II of the \"Flu Protection Act of 2004\" incentivizes the construction of vaccine manufacturing facilities. The \"Flu Protection Act of 2004\" includes a Vaccine Manufacturing Facilities Investment Tax Credit, offering a 20% credit for qualified investments in vaccine manufacturing facilities. The \"Flu Protection Act of 2004\" offers a 20% tax credit for qualified investments in vaccine manufacturing facilities. The qualified investment is based on the basis of vaccine manufacturing facilities property placed in service during the taxable year. Vaccine manufacturing facilities property includes real and tangible personal property used for vaccine manufacture, distribution, or research and development. The \"Flu Protection Act of 2004\" provides a 20% tax credit for qualified investments in vaccine manufacturing facilities. The qualified investment is for property used in vaccine manufacture, distribution, or research and development, and must comply with relevant regulations. Certain expenditure rules apply, and the provision does not apply to property placed in service after December 31, 2008. Technical amendments are also made to the tax code. The tax code is amended to include a new clause regarding the basis of vaccine manufacturing facilities property. Additionally, section 48 is amended to include reference to section 48(c)(4). The section heading for section 48 is also updated. The tax code is amended to include a new clause regarding vaccine manufacturing facilities property. The amendments made by this section apply to property placed in service after December 31, 2003. Additionally, a new section is added to ensure sufficient flu vaccine supply under the Public Health Service Act. The Director must contract with manufacturers by March 15 each year for additional influenza vaccine doses as needed. Manufacturers will be compensated for unsold doses requested by the Director. The Director may purchase contracted vaccine doses when they are unlikely to be absorbed by the private market. States are encouraged to develop a contingency plan for high-risk populations in case of vaccine delays or shortages. Authorization of appropriations is provided for this purpose. TITLE IV--PREPARING FOR A PANDEMIC OR EPIDEMIC\n\nSEC. 401. PREPARATION FOR INFLUENZA PANDEMIC OR EPIDEMIC. This section amends the Public Health Service Act to include preparation for influenza pandemic or epidemic. The Secretary, through the Director, will establish a protocol to prevent, prepare for, and respond to influenza pandemics or epidemics. The protocol will address coordinating vaccine distribution, expanding manufacturing capacity, and improving vaccine production methods. The protocol established by the Secretary and the Director will address various aspects of influenza prevention and response, including alternative vaccine production methods, annual vaccine doses and strains, public education, antiviral medications, and tracking vaccine supply. The Director will coordinate with stakeholders, conduct surveillance, build State capacity, collect vaccine data, and assist with preparedness for rapid response to an influenza pandemic. The text chunk discusses the rapid state and local response to an influenza pandemic, exploring ways to make the vaccine more accessible, and developing systems to measure the impact on pediatric and high-risk populations. Authorization of appropriations is set at $100,000,000 for each fiscal year from 2004 to 2008. SEC. 501. MANUFACTURER WITHDRAWAL FROM THE MARKET. Title XXI of the Public Health Service Act is amended to include provisions for manufacturer withdrawal from the market."
}